The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.
Isomorphic Labs, Google’s A.I. Drug Business, Raises Money From Thrive
RELATED ARTICLES
Beijing’s crackdown on solar panel oversupply ‘too little, too late’: US advisory firm
Judge dismisses New York mayor’s corruption case, but slams Trump admin’s ‘bargain’
China showcases its role as a stabilising force amid US turbulence
